Europe's healthcare technologies are growing significantly, with industry and medical profession-driven developments revolutionising the delivery of healthcare
In most healthcare organisations, supply chain is treated purely as a role player that is insignificant in the overall strategy of the organisation. Supply chain-related decisions are tactical at best and focus primarily on supporting or delivering organisational performance objectives. If the role of supply chain is elevated and incorporated in the overall strategy, then it can be used to enhance the overall performance by improving the effectiveness of the available assets and resources.
New analysis from Frost & Sullivan (medicaldevices.frost.com), An Overview of Medical Device Supply Chain and Trends in Europe, covers the three main regions for the world medical device supply chain management market – the United States, Europe and Japan. The United States accounted for the highest revenue share with approximately 45 per cent, followed by the EU countries with 30 per cent and Rest-of-World (ROW) with 25 per cent.
Nowadays, supply chains are suffering from a high complexity, due to several causes, such as customer tailored and elaborate products, global procurement and distribution, or technological innovations. Complexity management becomes a major task of today's business management because of the direct link between the efficiency and the complexity of a supply chain.
"Real-time visibility has become an imperative strategic factor to support the business model in such a high-velocity, complex and distributed logistics environment," says Frost & Sullivan Research Analyst SreeVidhya Praveen. "Visibility to suppliers' production rates and shipment lead times, in-house inventory, historical data, and customer sales projections can drive benefits in efficiency, lower inventories and improve fulfilment rates."
The healthcare sector is different as financial and information flows play a critical role in the key supply chain design decisions. In some segments of the healthcare sector, it is important for the manufacturer to be in direct contact with the clinician when the former requires critical knowledge for the optimal use of product. Therefore, a manufacturer sells directly to providers and avoids distributors, which, in turn, affects the structure of the underlying supply chain.
However, supply chain rationalisation has resulted in a severe downsizing of the supply base and a preference on the part of corporations to rely on a few preferred suppliers. Additionally, average contract sizes are increasing, as companies are buying from fewer suppliers, making it difficult for smaller groups to compete.
Companies should be more proactive and systematic in their supply chain operations, improve on-time delivery and reduce lead time as well as lead-time variability.
"In order to facilitate success, suppliers must develop the capabilities and competencies necessary to leverage their relationships with large corporations for profit," concludes SreeVidhya.
If you are interested in more information on this study, please send an email to Katja Feick, Corporate Communications, at katja.feick[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.
An Overview of Medical Device Supply Chain and Trends in Europe is part of the Medical Devices Growth Partnership Services programme, which also includes research in the following markets: An Overview of Ulceration Wounds, European Braces and Supports Market, Western European Market for Image Guided and Robotic Surgery, Key Trends and Indicators in the European Healthcare Markets, Surgical Drapes, Gowns and Gloves Market in Europe, Sterilisation and Disinfection equipment Market in Eastern Europe, Overview of the Healthcare Industry in Russia and Other CIS Countries, European IV Therapy and Enteral Nutrition Devices Market, and Western European Percutaneous Coronary Intervention Devices Market, among others. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.
An Overview of Medical Device Supply Chain and Trends in Europe / M556